Compare BridgeBio Pharma Inc (BBIO) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Taskus Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Taskus Inc trades at $5.61 (market cap $514.67M). The key difference: BridgeBio Pharma Inc is far larger — about 31.6× Taskus Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | TASK | |
|---|---|---|
Market Cap | $16.27B | $514.67M |
Sector | Health | Technology |
52-Week High | $90.17 | $18.21 |
52-Week Low | $44.81 | $4.57 |
Enterprise Value | $17.82B | $910.37M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
